Literature DB >> 10502501

Metabolism of methyl tert-butyl ether and other gasoline ethers by human liver microsomes and heterologously expressed human cytochromes P450: identification of CYP2A6 as a major catalyst.

J Y Hong1, Y Y Wang, F Y Bondoc, M Lee, C S Yang, W Y Hu, J Pan.   

Abstract

To reduce the production of carbon monoxide and other pollutants in motor vehicle exhaust, methyl tert-butyl ether (MTBE), ethyl tert-butyl ether (ETBE), and tert-amyl methyl ether (TAME) are added to gasoline as oxygenates for more complete combustion. Previously, we demonstrated that human liver is active in metabolizing MTBE to tert-butyl alcohol (TBA) and that cytochrome P450 (CYP) enzymes play a critical role in the metabolism of MTBE. The present study demonstrates that human liver is also active in the oxidative metabolism of ETBE and TAME. A large interindividual variation in metabolizing these gasoline ethers was observed in 15 human liver microsomal samples. The microsomal activities in metabolizing MTBE, ETBE, and TAME were highly correlated among each other (r, 0.91-0. 96), suggesting that these ethers are metabolized by the same enzyme(s). Correlation analysis of the ether-metabolizing activities with individual CYP enzyme activities in the liver microsomes showed that the highest degree of correlation was with human CYP2A6 (r, 0. 90-0.95), which is constitutively expressed in human livers and known to be polymorphic. CYP2A6 displayed the highest turnover number in metabolizing gasoline ethers among a battery of human CYP enzymes expressed in human B-lymphoblastoid cells. Kinetic studies on MTBE metabolism with three human liver microsomes exhibited apparent Km values that ranged from 28 to 89 microM and the V(max) values from 215 to 783 pmol/min/mg, with similar catalytic efficiency values (7.7 to 8.8 microl/min/mg protein). Metabolism of MTBE, ETBE, and TAME by human liver microsomes was inhibited by coumarin, a known substrate of human CYP2A6, in a concentration-dependent manner. Monoclonal antibody against human CYP2A6 caused a significant inhibition (75% to 95%) of the metabolism of MTBE, ETBE, and TAME in human liver microsomes. Taken together, these results clearly indicate that in human liver, CYP2A6 is the major enzyme responsible for the metabolism of MTBE, ETBE, and TAME. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10502501     DOI: 10.1006/taap.1999.8750

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  6 in total

Review 1.  Polymorphisms of CYP2A6 and its practical consequences.

Authors:  H Raunio; A Rautio; H Gullstén; O Pelkonen
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

2.  Methyl tert butyl ether targets developing vasculature in zebrafish (Danio rerio) embryos.

Authors:  Josephine A Bonventre; Lori A White; Keith R Cooper
Journal:  Aquat Toxicol       Date:  2011-05-13       Impact factor: 4.964

Review 3.  Epidemiology, toxicokinetics, and health effects of methyl tert-butyl ether (MTBE).

Authors:  Scott Phillips; Robert B Palmer; Aaron Brody
Journal:  J Med Toxicol       Date:  2008-06

4.  Persistence of methyl tertiary butyl ether (MTBE) against metabolism by Danish vegetation.

Authors:  Stefan Trapp; Xiaozhang Yu; Hans Mosbaek
Journal:  Environ Sci Pollut Res Int       Date:  2003       Impact factor: 4.223

5.  Health Risk Assessment for Inhalation Exposure to Methyl Tertiary Butyl Ether at Petrol Stations in Southern China.

Authors:  Dalin Hu; Jianping Yang; Yungang Liu; Wenjuan Zhang; Xiaowu Peng; Qinzhi Wei; Jianhui Yuan; Zhiliang Zhu
Journal:  Int J Environ Res Public Health       Date:  2016-02-06       Impact factor: 3.390

6.  Physiologically based pharmacokinetic model for ethyl tertiary-butyl ether and tertiary-butyl alcohol in rats: Contribution of binding to α2u-globulin in male rats and high-exposure nonlinear kinetics to toxicity and cancer outcomes.

Authors:  Susan J Borghoff; Caroline Ring; Marcy I Banton; Teresa L Leavens
Journal:  J Appl Toxicol       Date:  2016-11-24       Impact factor: 3.446

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.